Does endoscopic sphincterotomy contribute to the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis after endoscopic biliary stenting for malignant biliary obstruction? A multicenter prospective cohort study.
Endoscopic biliary stenting
Endoscopic sphincterotomy
Malignant biliary obstruction
Plastic and metal stent
Post-endoscopic retrograde cholangiopancreatography pancreatitis
Prospective cohort
Journal
Surgical endoscopy
ISSN: 1432-2218
Titre abrégé: Surg Endosc
Pays: Germany
ID NLM: 8806653
Informations de publication
Date de publication:
05 2023
05 2023
Historique:
received:
08
09
2022
accepted:
05
12
2022
medline:
5
5
2023
pubmed:
28
12
2022
entrez:
27
12
2022
Statut:
ppublish
Résumé
There is no consensus on the necessity of endoscopic sphincterotomy (ES) to prevent post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP) after endoscopic stenting in patients with malignant biliary obstruction. We investigated the incidence of PEP after endoscopic biliary stenting for malignant biliary obstruction with or without ES in a multicenter prospective cohort study. We enrolled 807 patients who underwent endoscopic biliary stenting for malignant biliary obstruction with a native papilla at 36 hospitals between April 2017 and March 2018. The incidence of PEP in patients with or without ES was compared for subgroups based on stent type, placement method, and patient background. Univariate and multivariate analysis was performed to investigate the incidence of PEP in all stenting patients. Plastic and metal stents (MS) were inserted in 598 and 209 patients, respectively. The incidence of PEP in patients with or without ES was 7.9% and 7.4%, respectively among all stenting patients. The incidences of PEP with or without ES in plastic stent insertion patients, patients with MS insertion, stent insertions across the papilla, stent insertions across the papilla in patients without main pancreatic duct obstruction, and fully covered MS insertions across the papilla were compared. There was no overall significant difference in the incidence of PEP between those with or without ES. Multivariate logistic regression analysis for the incidence of PEP in all stenting patients revealed obstruction of the main pancreatic duct at the pancreatic head and epinephrine spraying on the papilla were significant factors; there was no significant difference in the incidence of PEP between patients with or without ES. Endoscopic sphincterotomy may not contribute to the prevention of PEP after endoscopic biliary stenting for malignant biliary obstruction, even in cases of insertion with a fully covered MS across the papilla.
Sections du résumé
BACKGROUND
There is no consensus on the necessity of endoscopic sphincterotomy (ES) to prevent post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP) after endoscopic stenting in patients with malignant biliary obstruction. We investigated the incidence of PEP after endoscopic biliary stenting for malignant biliary obstruction with or without ES in a multicenter prospective cohort study.
METHODS
We enrolled 807 patients who underwent endoscopic biliary stenting for malignant biliary obstruction with a native papilla at 36 hospitals between April 2017 and March 2018. The incidence of PEP in patients with or without ES was compared for subgroups based on stent type, placement method, and patient background. Univariate and multivariate analysis was performed to investigate the incidence of PEP in all stenting patients.
RESULTS
Plastic and metal stents (MS) were inserted in 598 and 209 patients, respectively. The incidence of PEP in patients with or without ES was 7.9% and 7.4%, respectively among all stenting patients. The incidences of PEP with or without ES in plastic stent insertion patients, patients with MS insertion, stent insertions across the papilla, stent insertions across the papilla in patients without main pancreatic duct obstruction, and fully covered MS insertions across the papilla were compared. There was no overall significant difference in the incidence of PEP between those with or without ES. Multivariate logistic regression analysis for the incidence of PEP in all stenting patients revealed obstruction of the main pancreatic duct at the pancreatic head and epinephrine spraying on the papilla were significant factors; there was no significant difference in the incidence of PEP between patients with or without ES.
CONCLUSION
Endoscopic sphincterotomy may not contribute to the prevention of PEP after endoscopic biliary stenting for malignant biliary obstruction, even in cases of insertion with a fully covered MS across the papilla.
Identifiants
pubmed: 36575219
doi: 10.1007/s00464-022-09823-5
pii: 10.1007/s00464-022-09823-5
doi:
Types de publication
Multicenter Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
3463-3470Informations de copyright
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Simmons DT, Petersen BT, Gostout CJ, Levy MJ, Topazian MD, Baron TH (2008) Risk of pancreatitis following endoscopically placed large-bore plastic biliary stents with and without biliary sphincterotomy for management of postoperative bile leaks. Surg Endosc 22:1459–1463. https://doi.org/10.1007/s00464-007-9643-8
doi: 10.1007/s00464-007-9643-8
pubmed: 18027045
Tarnasky PR, Cunningham JT, Hawes RH, Hoffman BJ, Uflacker R, Vujic I, Cotton PB (1997) Transpapillary stenting of proximal biliary strictures: Does biliary sphincterotomy reduce the risk of postprocedure pancreatitis? Gastrointest Endosc 45:46–51. https://doi.org/10.1016/S0016-5107(97)70301-8
doi: 10.1016/S0016-5107(97)70301-8
pubmed: 9013169
Kato S, Kuwatani M, Hayashi T, Eto K, Ono M, Ehira N, Yamato H, Sano I, Taya Y, Onodera M, Kubo K, Ihara H, Yamazaki H, Sakamoto N (2020) Inutility of endoscopic sphincterotomy to prevent pancreatitis after biliary metal stent placement in the patients without pancreatic duct obstruction. Scand J Gastroenterol 55:503–508. https://doi.org/10.1080/00365521.2020.1749879
doi: 10.1080/00365521.2020.1749879
pubmed: 32275454
Dumonceau JM, Kapral C, Aabakken L, Papanikolaou IS, Tringali A, Vanbiervliet G, Beyna T, Dinis-Ribeiro M, Hritz I, Mariani A, Paspatis G, Radaelli F, Lakhtakia S, Veitch AM, Van Hooft JE (2020) ERCP-related adverse events: European society of gastrointestinal endoscopy (ESGE) guideline. Endoscopy 52:127–149. https://doi.org/10.1055/a-1075-4080
doi: 10.1055/a-1075-4080
pubmed: 31863440
Martins FP, Kahaleh M, Ferrari AP (2015) Management of liver transplantation biliary stricture: Results from a tertiary hospital. World J Gastrointest Endosc 7:747. https://doi.org/10.4253/wjge.v7.i7.747
doi: 10.4253/wjge.v7.i7.747
pubmed: 26140103
pmcid: 4482835
Kato S, Kuwatani M, Onodera M, Kudo T, Sano I, Katanuma A, Uebayashi M, Eto K, Fukasawa M, Hashigo S, Iwashita T, Yoshida M, Taya Y, Kawakami H, Kato H, Nakai Y, Kobashigawa K, Kawahata S, Shinoura S, Ito K, Kubo K, Yamato H, Hara K, Maetani I, Mukai T, Shibukawa G, Itoi T (2021) Risk of pancreatitis following biliary stenting with/without endoscopic sphincterotomy: A randomized controlled trial. Clin Gastroenterol Hepatol 20:P1394-1403. https://doi.org/10.1016/j.cgh.2021.08.016
doi: 10.1016/j.cgh.2021.08.016
Zhou H, Li L, Zhu F, Luo SZ, Cai XB, Wan XJ (2012) Endoscopic sphincterotomy associated cholangitis in patients receiving proximal biliary self-expanding metal stents. Hepatobiliary Pancreat Dis Int 11:643–649. https://doi.org/10.1016/S1499-3872(12)60238-0
doi: 10.1016/S1499-3872(12)60238-0
pubmed: 23232637
Cui PJ, Yao J, Zhao YJ, Han HZ, Yang J (2014) Biliary stenting with or without sphincterotomy for malignant biliary obstruction: A meta-analysis. World J Gastroenterol 20:14033–14039. https://doi.org/10.3748/WJG.V20.I38.14033
doi: 10.3748/WJG.V20.I38.14033
pubmed: 25320543
pmcid: 4194589
Di Giorgio P, De Luca L, Rivellini G, Cassandro R, Lizza M, De Luca B (2000) A comparison of the outcomes of treatments with plastic stent (PS) with and without endoscopic sphincterotomy (ES) for inoperable malignant common bile duct obstruction. Dig Liver Dis 32:A61. https://doi.org/10.1016/s1590-8658(00)80422-3
doi: 10.1016/s1590-8658(00)80422-3
Margulies C, Siqueira ES, Silverman WB, Lin XS, Martin JA, Rabinovitz M, Slivka A (1999) The effect of endoscopic sphincterotomy on acute and chronic complications of biliary endoprostheses. Gastrointest Endosc 49:716–719. https://doi.org/10.1016/S0016-5107(99)70288-9
doi: 10.1016/S0016-5107(99)70288-9
pubmed: 10343215
Nakahara K, Okuse C, Suetani K, Michikawa Y, Kobayashi S, Otsubo T, Itoh F (2013) Covered metal stenting for malignant lower biliary stricture with pancreatic duct obstruction: Is endoscopic sphincterotomy needed? Gastroenterol Res Pract 2013:12–15. https://doi.org/10.1155/2013/375613
doi: 10.1155/2013/375613
Hayashi T, Kawakami H, Osanai M, Ishiwatari H, Naruse H, Hisai H, Yanagawa N, Kaneto H, Koizumi K, Sakurai T, Sonoda T (2015) No benefit of endoscopic sphincterotomy before biliary placement of self-expandable metal stents for unresectable pancreatic cancer. Clin Gastroenterol Hepatol 13:1151-1158.e2. https://doi.org/10.1016/j.cgh.2015.01.008
doi: 10.1016/j.cgh.2015.01.008
pubmed: 25632802
Artifon ELA, Sakai P, Ishioka S, Marques SB, Lino AS, Cunha JEM, Jukemura J, Cecconello I, Carrilho FJ, Opitz E, Kumar A (2008) Endoscopic sphincterotomy before deployment of covered metal stent is associated with greater complication rate: A prospective randomized control trial. J Clin Gastroenterol 42:815–819. https://doi.org/10.1097/MCG.0b013e31803dcd8a
doi: 10.1097/MCG.0b013e31803dcd8a
pubmed: 18285718
Shimizu S, Naitoh I, Nakazawa T, Hayashi K, Miyabe K, Kondo H, Yoshida M, Yamashita H, Umemura S, Hori Y, Ohara H, Joh T (2013) Predictive factors for pancreatitis and cholecystitis in endoscopic covered metal stenting for distal malignant biliary obstruction. J Gastroenterol Hepatol 28:68–72. https://doi.org/10.1111/j.1440-1746.2012.07283.x
doi: 10.1111/j.1440-1746.2012.07283.x
pubmed: 23020651
Andriulli A, Loperfido S, Napolitano G, Niro G, Valvano MR, Spirito F, Pilotto A, Forlano R (2007) Incidence rates of post-ERCP complications: A systematic survey of prospective studies. Am J Gastroenterol 102:1781–1788. https://doi.org/10.1111/j.1572-0241.2007.01279.x
doi: 10.1111/j.1572-0241.2007.01279.x
pubmed: 17509029
Fujita K, Yazumi S, Matsumoto H, Asada M, Nebiki H, Matsumoto K, Maruo T, Takenaka M, Tomoda T, Onoyama T, Kurita A, Ueki T, Katayama T, Kawamura T, Kawamoto H (2021) Multicenter prospective cohort study of adverse events associated with biliary ERCP; Incidence of adverse events and preventive measures for post-endoscopic retrogrde cholangiopancreatography pancreatitis. Dig Endosc 34:1198–1204. https://doi.org/10.1111/den.14225
doi: 10.1111/den.14225
Cotton PB, Eisen GM, Aabakken L, Baron TH, Hutter MM, Jacobson BC, Mergener K, Nemcek A, Petersen BT, Petrini JL, Pike IM, Rabeneck L, Romagnuolo J, Vargo JJ (2010) A lexicon for endoscopic adverse events: Report of an ASGE workshop. Gastrointest Endosc 71:446–454. https://doi.org/10.1016/j.gie.2009.10.027
doi: 10.1016/j.gie.2009.10.027
pubmed: 20189503
Matsushita M, Takakuwa H, Shimeno N, Uchida K, Nishio A, Okazaki K (2009) Epinephrine sprayed on the papilla for prevention of post-ERCP pancreatitis. J Gastroenterol 44:71–75. https://doi.org/10.1007/s00535-008-2272-8
doi: 10.1007/s00535-008-2272-8
pubmed: 19159075
Isayama H, Nakai Y, Hamada T, Matsubara S, Kogure H, Koike K (2016) Understanding the mechanical forces of self-expandable metal stents in the biliary ducts. Curr Gastroenterol Rep 18:1–6. https://doi.org/10.1007/s11894-016-0538-5
doi: 10.1007/s11894-016-0538-5
Tamura T, Ogura T, Takenaka M, Tanioka K, Itonaga M, Yamao K, Kamata K, Hirono S, Okada K, Imanishi M, Higuchi K, Yamaue H, Kitano M (2020) Endoscopic sphincterotomy to prevent post-ERCP pancreatitis in patients with biliary neoplasms: A multicenter retrospective cohort study. Endosc Int Open 08:E513–E522. https://doi.org/10.1055/a-1107-2629
doi: 10.1055/a-1107-2629
Elshimi E, Morad W, Elshaarawy O, Attia A (2020) Optimization of biliary drainage in inoperable distal malignant strictures. World J Gastrointest Endosc 12:285–296. https://doi.org/10.4253/wjge.v12.i9.285
doi: 10.4253/wjge.v12.i9.285
pubmed: 32994859
pmcid: 7503617
Tamura T, Itonaga M, Ashida R, Yamashita Y, Hatamaru K, Kawaji Y, Emori T, Kitahata Y, Miyazawa M, Hirono S, Okada K, ichi, Kawai M, Shimokawa T, Yamaue H, Kitano M, (2021) Covered self-expandable metal stents versus plastic stents for preoperative biliary drainage in patient receiving neo-adjuvant chemotherapy for borderline resectable pancreatic cancer: Prospective randomized study. Dig Endosc 33:1170–1178. https://doi.org/10.1111/den.13926
doi: 10.1111/den.13926
pubmed: 33410564
Akshintala VS, Hutfless SM, Colantuoni E, Kim KJ, Khashab MA, Li T, Elmunzer BJ, Puhan MA, Sinha A, Kamal A, Lennon AM, Okolo PI, Palakurthy MK, Kalloo AN, Singh VK (2013) Systematic review with network meta-analysis: Pharmacological prophylaxis against post-ERCP pancreatitis. Aliment Pharmacol Ther 38:1325–1337. https://doi.org/10.1111/apt.12534
doi: 10.1111/apt.12534
pubmed: 24138390
Xu LH, Qian JB, Gu LG, Qiu JW, Ge ZM, Lu F, Wang YM, Li YM, Lu HS (2011) Prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis by epinephrine sprayed on the papilla. J Gastroenterol Hepatol 26:1139–1144. https://doi.org/10.1111/j.1440-1746.2011.06718.x
doi: 10.1111/j.1440-1746.2011.06718.x
pubmed: 21392105
Sawas T, Arwani N, Al Halabi S, Vargo J (2017) Sphincterotomy with endoscopic biliary drainage for severe acute cholangitis: a meta-analysis. Endosc Int Open 05:E103–E109. https://doi.org/10.1055/s-0042-120412
doi: 10.1055/s-0042-120412